Sanofi profits down despite growth at Genzyme unit


Drugmaker Sanofi has reported an 11 percent fall in profit in the second quarter despite double-digit growth of its biotech unit Genzyme. The Paris-based company reported Friday a fall in net income of 11 percent to 1.16 billion euros and a 5 percent drop in net revenue to 8.14 billion euros.



from Biotech News